Dallas, TX 的 腎衰竭 臨床試驗
9 項針對 腎衰竭 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
招募中2/3 期
- Dallas V.A. Medical Center, Dallas
- Dallas Nephrology Associates, Dallas
- US Renal Care, Dallas
Pivotal Study of the Velocity™ pAVF System
招募中
- Advanced Dallas Hospital, Dallas
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
招募中1/2 期歡迎健康志工
- Research Site, Dallas
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
招募中
- University of Texas Southwestern Medical Center, Dallas
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
招募中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
招募中觀察性研究
- Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
招募中
- Baylor Scott & White Heart and Vascular Hospital, Dallas
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
招募中3 期
- University of Texas Southwestern, Dallas
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
招募中
- Baylor Heart and Vascular, Dallas
其他城市的 腎衰竭 試驗
- Boston, MA14 項研究
- Houston, TX13 項研究
- New York City, NY7 項研究
- Orlando, FL7 項研究
- Chicago, IL7 項研究
- Queens, NY6 項研究
- Phoenix, AZ5 項研究
- Durham, NC5 項研究
- Baltimore, MD5 項研究
- Atlanta, GA5 項研究
- Greenville, SC4 項研究
- Charlotte, NC4 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 膀胱癌27 項研究
- 肺癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。